跳至主要内容
临床试验/NCT06662734
NCT06662734已完成不适用

Infantile Versus Adult-type Fibrosarcoma and the Risk of Multiple Primary Malignancies: a Retrospective Cohort Based on SEER Database

asmaa salama ibrahim1 个研究点 分布在 1 个国家目标入组 12,783 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12,783
试验地点
1
主要终点
The standardized incidence ratio and excess risk of developing multiple primary malignancies following fibrosarcoma diagnosis

研究概览

简要总结

Fibrosarcoma is a malignant tumor originating from mesenchymal tissues and consists of fibroblasts with various types of collagen production. It represents 10% of musculoskeletal sarcomas and less than 5% of all primary bone tumors. It affects middle-aged patients with the most common location in the femur and 70% long tubular bones. Studies reported that fibrosarcoma patients tend to develop a subsequent primary malignancy, the analysis showed a higher risk of SPMs even a decade following the initial diagnosis of fibrosarcoma.

SPMs affect the long-term survival of patients with soft tissue tumors, and since there are no available studies analyzing the risk of second primary malignancies in different types of fibrosarcomas, especially the infantile and adult-type. Therefore, the purpose of this study was to assess the risk of second primary malignancies following primary fibrosarcoma diagnosis for a better understanding of the nature of this rare neoplasm. The investigators used the Surveillance, Epidemiology and End Results (SEER) database to extract the data and calculate the standardized incidence ratio as Observed/Expected and the Excess risk for second primary malignancies with 95% Confidence Interval. Significance was achieved at 0.05.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with fibrosarcoma from 2000 to
  • Sequence 0 or
  • Histological types:
  • Infantile fibrosarcoma, Fibromyxosarcoma, Periosteal fibrosarcoma, Facial fibrosarcoma, Dermatofibrosarcoma, Central odontogenic fibrosarcoma, Ameloblastic fibrosarcoma

排除标准

  • Patients with unknown histology type

结局指标

主要结局

The standardized incidence ratio and excess risk of developing multiple primary malignancies following fibrosarcoma diagnosis

时间窗: from Jan, 2000 till Dec, 2021

The surveillance, epidemiology and End Results (SEER) database was used to calculate the standardized incidence ratio (SIR) as Observed/Expected (O/E) and calculated the Excess absolute risk for Multiple primary malignancies for fibrosarcoma patients

The standardized incidence ratio and excess risk of developing second primary malignancies for different subtypes of fibrosarcoma

时间窗: from Jan, 2000 till Dec, 2021

次要结局

  • The standardized incidence ratio and excess risk of multiple primary malignancies in fibrosarcoma patients across different racial groups(from Jan, 2000 till Dec, 2021)
  • The standardized incidence ratio and excess risk of multiple primary malignancies in both males and females in fibrosarcoma patients(from Jan, 2000 till Dec, 2021)

研究者

发起方
asmaa salama ibrahim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

asmaa salama ibrahim

Resident physician of gastroenterology

Suez Canal University

研究点 (1)

Loading locations...

相似试验